Instrument Inactif

Communiqués Surgalign Holdings, Inc.

Actions

SRGA

US86882C2044

Equipement et technologie médicale avancés

Communiqués

10/07/24	Surgalign : RTI Surgical appoints Chad Croasdale as Chief Commercial Officer	PU
28/11/23	RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva Allograft Dermis in Breast Reconstruction	AQ
27/11/23	Surgalign : RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction	PU
30/09/23	Surgalign : Bankruptcy - Form 8-K	PU
28/07/23	Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales	GL
28/07/23	Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales	AQ
23/06/23	SURGALIGN HOLDINGS, INC. : Regulation FD Disclosure (form 8-K)	AQ
23/06/23	Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing	AQ
20/06/23	Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code	AQ
20/06/23	Surgalign : Costs Associated with Exit/Disposal - Form 8-K	PU
15/06/23	Surgalign : Management Change/Compensation - Form 8-K	PU
09/06/23	Surgalign : Failure to Satisfy Listing Rule - Form 8-K	PU
24/05/23	Surgalign to Participate at ISASS 2023, 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources	AQ
23/05/23	Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources	AQ
11/05/23	Surgalign: Q1 Earnings Snapshot	AQ
11/05/23	Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations	AQ
08/05/23	Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research	AQ
04/05/23	Surgalign to Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO AI Insights and its Artificial Intelligence Technologies	AQ
04/05/23	Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023	AQ
03/05/23	Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies	AQ
24/04/23	Surgalign reveals renewed emphasis of artificial intelligence to treat spinal conditions	AQ
13/04/23	SURGALIGN HOLDINGS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
13/04/23	Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance	GL
30/03/23	Surgalign: Q4 Earnings Snapshot	AQ
30/03/23	SURGALIGN HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	AQ